Login to Your Account



HGS Gets Cancer-Fighting Molecule

Aegera, Nektar Add Millions To Coffers In Year-End Deals

By Donna Young


Friday, December 21, 2007
Biotechs continued rushing to finalize deals before the year-end, with Human Genome Sciences Inc. and Montreal-based Aegera Therapeutics Inc. teaming up in a $315 million agreement to develop and commercialize cancer cell-killing molecules. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription